Statistics

Total Visits

Views
PCSK9 inhibition with alirocumab decreases plasma lipoprotein(a) concentration by a dual mechanism of action in statin‐treated patients with very high apolipoprotein(a) concentration 1000

Total Visits per Month

April 2024 May 2024 June 2024 July 2024 August 2024 September 2024 October 2024
PCSK9 inhibition with alirocumab decreases plasma lipoprotein(a) concentration by a dual mechanism of action in statin‐treated patients with very high apolipoprotein(a) concentration 2 8 16 0 2 0 0

File Downloads

Views

Top Country Views

Views
Australia 974
United States 14
Argentina 2
Canada 2
India 2
Iran 2
Mongolia 2
Sweden 2

Top City Views

Views
Armidale 580
Melbourne 200
Louisville 6
Northmead 6
Crawley 4
San Mateo 4
Ashtonfield 2
Bangalore 2
Boardman 2
Kingston 2